Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Steven M. Bray
Observed names:
Steve Bray,
Steve M. Bray,
Steven Bray,
Steven M Bray
Institution:
Ivy Tech Community College of Indiana
Observed institutions:
Brigham Young University,
Ivy Tech Community College of Indiana,
Emory University,
Eli Lilly (United States),
Duke University,
Duke Medical Center,
Indianapolis Public Library
show all 7
ORCID:
0000-0002-0854-8121
Observed ORCID:
0000-0002-0854-8121
OpenAlex ID:
A5066378604
Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective
2011
·
Michael R. Santoro
, Steven M. Bray
, et al.
·
Annual Review of Pathology Mechanisms of Disease
·
543
Taste Perception and Coding in Drosophila
2004
·
Natasha Thorne
, Caroline Chromey
, et al.
·
Current Biology
·
429
PDF
A Putative Drosophila Pheromone Receptor Expressed in Male-Specific Taste Neurons Is Required for Efficient Courtship
2003
·
Steven Bray
, Hubert Amrein
·
Neuron
·
292
PDF
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila
2008
·
Shuang Chang
, Steven M Bray
, et al.
·
Nature Chemical Biology
·
258
Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib
2017
·
Xueqian Gong
, Lacey M. Litchfield
, et al.
·
Cancer Cell
·
245
PDF
Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males
2010
·
Stephen C. Collins
, Steven M. Bray
, et al.
·
American Journal of Medical Genetics Part A
·
126
PDF
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population
2010
·
Steven M. Bray
, Jennifer G. Mulle
, et al.
·
Proceedings of the National Academy of Sciences
·
125
New perspectives on the biology of fragile X syndrome
2012
·
Tao Wang
, Steven M Bray
, et al.
·
Current Opinion in Genetics & Development
·
123
Genomic Characterization of Intrinsic and Acquired Resistance to Cetuximab in Colorectal Cancer Patients
2018
·
Steven M Bray
, Jeeyun Lee
, et al.
·
Scientific Reports
·
82
PDF
Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations
2017
·
Yung-mae M. Yao
, Gregory P. Donoho
, et al.
·
Clinical Cancer Research
·
45
Human Angiotensin II Type 1 Receptor Isoforms Encoded by Messenger RNA Splice Variants Are Functionally Distinct
2001
·
Mickey M. Martin
, Barry M. Willardson
, et al.
·
Molecular Endocrinology
·
42
PDF
Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis
2020
·
Jiangang Liu
, Yong Beom Cho
, et al.
·
Scientific Reports
·
38
PDF
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer
2022
·
Milan Radovich
, Jeffrey P. Solzak
, et al.
·
Clinical Cancer Research
·
35
PDF
Bitter-Sweet Solution in Taste Transduction
2003
·
Hubert Amrein
, Steve Bray
·
Cell
·
23
PDF
Regulation of Angiotensin II-induced G Protein Signaling by Phosducin-like Protein
2002
·
Joseph N. McLaughlin
, Craig D. Thulin
, et al.
·
Journal of Biological Chemistry
·
23
Evaluation of molecular subtypes and clonal selection during establishment of patient-derived tumor xenografts from gastric adenocarcinoma
2020
·
Anne-Lise Peille
, Vincent Vuaroqueaux
, et al.
·
Communications Biology
·
21
PDF
Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing
2022
·
Reynold C. Ly
, Tyler Shugg
, et al.
·
Journal of Molecular Diagnostics
·
18
PDF
Computational pharmacogenotype extraction from clinical next-generation sequencing
2023
·
Tyler Shugg
, Reynold C. Ly
, et al.
·
Frontiers in Oncology
·
13
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
2025
·
Tyler Shugg
, Katherine A. Gallaway
, et al.
·
Pediatric Pulmonology
·
3
PDF
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
2025
·
Hyunwoo Koo
, Tayler B. Smith
, et al.
·
Clinical Pharmacology & Therapeutics
·
3
PDF
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection
2025
·
Parvathi Sudha
, Phillip Pham
, et al.
·
Blood Advances
·
2
PDF
Fidelity of Next-Generation Sequencing to Predict Human Epidermal Growth Factor 2 Overexpression Across Solid Tumors
2025
·
Mya Tran
, Christopher A. Fausel
, et al.
·
JCO Precision Oncology
·
2
Pharmacokinetic Drug–Drug Interaction Potential of Oral Anticancer Drugs
2026
·
Fatimah Alhurayri
, Islam R. Younis
, et al.
·
Clinical Pharmacology & Therapeutics
·
1
Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer
2021
·
Philip S. Bernard
, Whitney Wooderchak-Donahue
, et al.
·
Cancers
·
1
PDF
Abstract 2647: Merestinib (LY2801653), targeting several oncokinases including NTRK1/2/3, shows potent anti-tumor effect in colorectal cell line- and patient-derived xenograft (PDX) model bearing TPM3-NTRK1 fusion
2016
·
Bruce W. Konicek
, Steve M. Bray
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
42
Citation count:
2,495
H-index:
17
I10-index:
18
Year
Topic
Type
